|
1 |
Overcoming solid tumor resistance to T cell recruiting bispecific antibodies by providing co-stimulation and checkpoint inhibition at the tumor site
Warwas, Karsten M.. - Heidelberg, 2022
|
|
|
|
2 |
Balancing efficacy and selectivity of bispecific c-METxEGFR antibodies
Sellmann, Carolin. - Darmstadt, 2016
|
|
|
|
3 |
Humanization, optimization and preclinical characterization of bispecific Endoglin antibodies for tumor-cell restricted activation of NK-cells
Pflügler, Martin Sebastian. - Tübingen, 2016
|
|
|
|
4 |
Bispecific Antibodies
Berlin : Springer Berlin, 2014
|
Ankündigung
|
|
|
5 |
Bispecific antibodies
Berlin : Springer, 2011
|
|
|
|
6 |
Anti-tumor activity, pharmacology and toxicology of EpCAM-, CD3-bispecific single-chain antibodies
Amann, Maria, 2009
|
|
|
|
7 |
Aspects of the mode of action of bispecific T cell engager (BiTE) antibodies
Hauff, Cornelia, 2009
|
|
|
|
8 |
Retargeting of cytokine induced killer cells against B-cell neoplasms using bispecific antibodies for adoptive immunotherapy
Tita-Nwa, Dinga Nkom Freddy, 2006
|
|
|
|
9 |
Bispecific antibodies
Fanger, Michael W.. - New York : Springer, 1995
|
|
Administration
